Staffan Strömberg, Ph.D.
Staffan has over 18 years of experience in the pharmaceutical industry. Besides his role as Head of Medical Devices at the Swedish Medical Products Agency, he has also been Vice President of Nicox France, and had management positions at AstraZeneca. Staffan has particularly experience in the development of orphan drugs as he was Head of R&D of Swedish Orphan.
Eamonn Connolly, Ph.D.
Head of Research and Development
Eamonn is the former VP Research of BioGaia, with 15 years experience working with pre-clinical and clinical research on live bacterial therapies. He has earlier extensive experience from the pharmaceutical industry including leading positions in R&D at Kabi Vitrum, Pharmacia & Upjohn and Fresenius Kabi.
Agneta Heierson, Ph.D.
Vice President Clinical Development
Agneta has over 25 years of experience working in the pharmaceutical industry. Most recently she has been the Global Vice President, R&D Supply Chain at AstraZeneca. Her extensive experience includes leading both global cross-functional drug development projects across all phases of development in different therapeutic areas, as well as leading clinical and pharmaceutical development organizations.
Chief Financial Officer
Daniel has 20 years experience from diverse U.S. and international management positions in finance and accounting with Investors Bank & Trust Co., Nordea Investment Management AB and Nordea Bank AB.
Michael Owens, B.S.B.A.
Michael has a background as Auditor at Arthur Andersen & Co. and Ernst & Young AB. He has held the position as CFO at Vitamex AB and as Financial Controller at Karolinska Development AB. Michael has 30+ years experience of finance of which two decades in the Nutritional Supplements and early stage Life Science industries.
Anders Kronström, M.Sc., M.B.A.
Chief Technical Officer
Anders has an extensive experience in the pharmaceutical industry with specialisation on pharmaceutical development, project leadership and business development.
Paul Alhadeff, B.Sc.
Head of Pharmaceutical Development and Manufacturing
Paul has more than two decades of experience in pharmaceutical development starting at Kabi Vitrum in 1989. During his career at AstraZeneca he has worked to bring several new drugs to the market, including Oxeeze Turbohaler and Symbicort.
Sanjiv Sharma, M.B.A.
Chief Commercial Officer
Sanjiv has a blend of successful experience in large, mid-size and start-up companies in North America and Asia, with national and global responsibility for companies like Sanofi, Valeant, and start-ups – NicOx and Duchesnay USA.
Christine Nguy, Pharm.D., M.Sc.
Business Development Analyst
Christine is a trained pharmacist specialised in industrial pharmacy with education and experience in bioentrepreneurship.
Leif Gallo, LL.M.
Leif has extensive experience in the pharmaceutical industry as in-house counsel with global and managerial responsibilities (AstraZeneca, Orexo).
Jin-Yu Lu, M.Sc.
Jin has education in life science and bioentrepreneurship. She has experience in administrative and operational support for R&D projects.
Crescent Yingyue Liao, M.Sc.
Crescent holds a Bachelor's degree in Biochemistry and a Master's degree in Bioentrepreneurship.